Exploratory clinical trial of blood CoQ10 concentration after one-week ingestion of reduced form CoQ10 (self- emulsifying formulation) in healthy men and women

Exploratory clinical trial of blood CoQ10 concentration after one-week ingestion of reduced form CoQ10 (self- emulsifying formulation) in healthy men and women - Exploratory clinical trial of blood CoQ10 concentration after ingestion of reduced form CoQ10 (self- emulsifying formulation)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020429

Enrollment

Registered

2016-01-05

Start date

2016-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Ingestion of reduced form CoQ10 (self- emulsifying formulation) consecutively for one week wash out period Ingestion of reduced form CoQ10 (slurry formulation) consecutively for one week Inges

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Healthy males and females aged 40 to 60 years 2)BMI >=18.5 kg/m2 and <25kg/m2

Exclusion criteria

Exclusion criteria: 1)Subjects who previous or present serious disease such digestive, liver, kidney, circulatory, blood, endocrine disorder. 2)Subjects who are taking medicine or being treated by a doctor 3)Subjects who are intend to undergo treatment or medication by a doctor during the test period. 4)Subjects who has a soy allergy 5)Subjects who smoke present or have smoked within the last one year prior to the current study 6)Subjects who use specified healthy food, functionality food, supplement. 7)Subjects who are intend to use specified healthy food, functionality food, supplement during the test period. 8)Subjects who perform high exercise intensity with fatigue the next day or sunburn. 9)Women who are pregnant or may be pregnant 10)Women who are breast-feeding 11)Subjects who are planning to participate in other clinical study 12)Subjects who are judged as unsuitable for the study by the investigator for other reason

Design outcomes

Primary

Measure	Time frame
Blood CoQ10 concentration after one-week ingestion of reduced form CoQ10 (self- emulsifying formulation)	—

Countries

Japan

Contacts

Public ContactMasaya Tsubokawa

FANCL Corporation Research Institute

tsubokawa_masaya@fancl.co.jp045-820-3659

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026